Gene · 3594
Papers2,084
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,084
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Crosstalk of Inflammatory Cytokines within the Breast Tumor Microenvironment. | Int J Mol Sci | 2023 | 36835413 | PubTator, text mining | PubMed |
| Loco-Regional Control and Sustained Difference in Serum Immune Protein Expression in Patients Treated for p16-Positive and p16-Negative Head and Neck Squamous Cell Carcinoma. | Int J Mol Sci | 2023 | 36835246 | PubTator, text mining | PubMed |
| Genetic adaptation to pathogens and increased risk of inflammatory disorders in post-Neolithic Europe. | Cell Genom | 2023 | 36819665 | PubTator, text mining | PubMed |
| Proteomic and transcriptomic screening demonstrates increased mast cell-derived CCL23 in systemic mastocytosis. | J Allergy Clin Immunol | 2023 | 36813186 | PubTator, text mining | PubMed |
| The roles of neutrophils in non-tuberculous mycobacterial pulmonary disease. | Ann Clin Microbiol Antimicrob | 2023 | 36800956 | PubTator, text mining | PubMed |
| Signaling pathways in rheumatoid arthritis: implications for targeted therapy. | Signal Transduct Target Ther | 2023 | 36797236 | PubTator, text mining | PubMed |
| Immunomodulation of Natural Killer Cell Function by Ribavirin Involves TYK-2 Activation and Subsequent Increased IFN-γ Secretion in the Context of In Vitro Hepatitis E Virus Infection. | Cells | 2023 | 36766795 | PubTator, text mining | PubMed |
| Clinical and Immunologic Characteristics of Non-Hematologic Cancers in Patients with Inborn Errors of Immunity. | Cancers (Basel) | 2023 | 36765721 | PubTator, text mining | PubMed |
| Human IL-23 is essential for IFN-γ-dependent immunity to mycobacteria. | Sci Immunol | 2023 | 36763636 | PubTator, text mining | PubMed |
| Biomarker-based clustering of patients with chronic obstructive pulmonary disease. | ERJ Open Res | 2023 | 36755966 | PubTator, text mining | PubMed |
| Interleukin-18 and IL-18BP in inflammatory dermatological diseases. | Front Immunol | 2023 | 36742296 | PubTator, text mining | PubMed |
| Disseminated multidrug-resistant tuberculosis and SARS-CoV-2 co-infection in a child with IL-12Rβ1 deficiency. | Indian J Tuberc | 2023 | 36740310 | PubTator, text mining | PubMed |
| Human IRF1 governs macrophagic IFN-γ immunity to mycobacteria. | Cell | 2023 | 36736301 | PubTator, text mining | PubMed |
| Significance of Interleukin 23 in Systemic Lupus Patients: Relation to Disease Activity and Damage Indices. | Biologics | 2023 | 36698375 | PubTator, text mining | PubMed |
| Predictive biomarkers for the responsiveness of recurrent glioblastomas to activated killer cell immunotherapy. | Cell Biosci | 2023 | 36694264 | PubTator, text mining | PubMed |
| Single-nucleus RNA sequencing and deep tissue proteomics reveal distinct tumour microenvironment in stage-I and II cervical cancer. | J Exp Clin Cancer Res | 2023 | 36683048 | PubTator, text mining | PubMed |
| How an Immune-Factor-Based Formulation of Micro-Immunotherapy Could Interfere with the Physiological Processes Involved in the Atopic March. | Int J Mol Sci | 2023 | 36675006 | PubTator, text mining | PubMed |
| Network-Based Assessment of Minimal Change Disease Identifies Glomerular Response to IL-7 and IL-12 Pathways Activation as Innovative Treatment Target. | Biomedicines | 2023 | 36672735 | PubTator, text mining | PubMed |
| The Adipocyte-Macrophage Relationship in Cancer: A Potential Target for Antioxidant Therapy. | Antioxidants (Basel) | 2023 | 36670988 | PubTator, text mining | PubMed |
| Investigation of the Molecular Evolution of Treg Suppression Mechanisms Indicates a Convergent Origin. | Curr Issues Mol Biol | 2023 | 36661528 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3594/papers?page=12